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Abstract
The safety of herbal products is one of the major concerns for the modernization of traditional Chinese medicine, 
and pharmacokinetic data of medicinal herbs guide us to design the rational use of the herbal formula. This article 
reviews the advantages of the automated blood sampling (ABS) systems for pharmacokinetic studies. In addition, three 
commonly used sample preparative methods, protein precipitation, liquid-liquid extraction and solid-phase extraction, 
are introduced. Furthermore, the definition, causes and evaluation of matrix effects in liquid chromatography-mass 
spectrometry (LC/MS) analysis are demonstrated. Finally, we present our previous works as practical examples of the 
application of ABS systems and LC/MS for the pharmacokinetic studies of Chinese medicinal herbs.
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Introduction
Chinese medicinal herbs have been used for treating 
ailments in China and Asia for several centuries, and 
are becoming more and more popular worldwide. The 
global market for phytopharmaceutical usage has been 
estimated at 60 billion US dollars in 2003, with an 
annual growth rate of at least 5% (Timmermans, 2003). 
People generally believe that medicinal herbs and 
botanical products have fewer adverse effects and are 
much safer than synthetic drugs. However, evidence-
based verification of the safety and efficacy of herbal 
medicinal products is still not comprehensive enough 
(Bhattaram et al., 2002). The safety issue of herbal 
medicinal products is becoming more widely recognized 
due to the increasing cases of adverse drug reactions 
and herb-drug pharmacokinetic interactions (Zeng 
and Jiang, 2010). In addition, a better understanding 
of the bioavailability and pharmacokinetics of herbal 
medicinal products will be helpful in determining 
reasonable dosage regimens. For these reasons, 
more effort has been put into the bioavailability and 
pharmacokinetics investigations of medicinal herbs. 
To examine the absorption, distribution, metabolism, 
and excretion of medicinal herbs and herbal products, 
we have to perform a serial blood sampling in rodents 
or other experimental animals to obtain the time-
concentration profile of the test compound, and 
the selection of the suitable bleeding method for 
pharmacokinetic evaluations relies on the study aim 
and physicochemical properties of compounds. Though 
This is an open access article under the CC BY-NC-ND license.
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the stress caused by anesthetics and restraint on the 
physiological status of experimental animals and drug 
metabolism have been proved (Mahl et al., 2000; Tabata 
et al., 1998; Vachon and Moreau, 2001), this issue is 
usually ignored when conducting pharmacokinetic 
evaluations. Another concern is the analytical method 
sensitivity, because the concentrations of the major 
herbal compounds in biological samples (e.g., plasma, 
bile, urine and tissue) usually fall within or lower than 
the microgram per liter range. Therefore, the analytical 
method requires sufficient sensitivity to acquire accurate 
pharmacokinetic results. High-performance liquid 
chromatography coupled to mass spectrometry (LC/MS) 
offering high selectivity and sensitivity has proven it 
the most powerful analytical tool for pharmacokinetics 
and drug discovery (Korfmacher, 2005; Papac and 
Shahrokh, 2001; Tolonen et al., 2009). 
In  th is  ar t ic le ,  we discussed two important 
technologies, the automated blood sampling (ABS) 
sys tem and  LC/MS,  for  the  pharmacokine t ic 
a p p l i c a t i o n s  o f  C h i n e s e  m e d i c i n a l  h e r b s .  A 
previous report had compared the impacts of tail-
bleeding, cannula and retro-orbital bleeding on the 
pharmacokinetics of six marketed drugs, and the authors 
suggested that cannulation with the ABS system could 
become the most efficient way for pharmaceutical 
industry to perform rat bioavailability, pharmacokinetic 
and toxicokinetic studies (Hui et al., 2007). In addition, 
we introduced the frequently used methods of sample 
preparation. Furthermore, we reviewed the issue of 
matrix effects of LC/MS analysis of biological samples. 
Finally, pharmacokinetics of polyphenolic compounds 
from three Chinese medicinal herbs, including green 
tea (綠茶 lǜ chá), turmeric (薑黃 jiāng huáng) and 
Cistanches Herba (肉蓯蓉 ròu cōng róng), were 
summarized and discussed. 
Blood sampling for pharmacokinetic 
studies
Blood can be obtained from animals using different 
bleeding techniques, such as the retro-orbital plexus 
sampling, tail  t ip amputation and jugular vein 
cannulation, which lead to various impacts on the 
animal’s physiological conditions because of the use 
of anesthetics and restraining of the animal. Isoflurane 
and pentobarbital have been reported to increase the 
stress of animals as indicated by elevated plasma 
glucose and corticosterone concentrations (Mahl et al., 
2000; Tabata et al., 1998; Vachon and Moreau, 2001). 
A suitable restrainer (e.g. a plastic tube) is used to 
immobilize conscious rodents for blood sampling to 
eliminate the influence of anesthetics, but this way is 
also very stressful to these animals, affecting animals’ 
physiology, biochemistry, metabolism and protein 
expression (Balcombe et al., 2004; Menguy, 1960; Xie 
et al., 2003). To lower the stress and effects of stress-
related hormones, it is needed to improve experimental 
procedures to lessen the stress caused by handling, 
restraint and sampling (Royo et al., 2004).  
A B S  s y s t e m s  h a v e  b e e n  p r o p o s e d  f o r 
pharmacokinetic studies of trans -resveratrol (Zhu et 
al., 2000), epigallocatechin gallate (Long et al., 2001), 
daphnoretin (Lin et al., 2005) and plumbagin (Hsieh 
et al., 2006) in rodents to minimize the stress due to 
the restrain and anesthesia. Generally, the ABS system 
consists of a robotic sampling module and an animal 
cage. The module equips with a syringe pump, a special 
5-way joint, 4 pinch valves, and optical sensors and is 
controlled by a computer to withdraw sample from the 
jugular vein catheter of the animal. During the sampling 
process, blood is sandwiched by air gaps in order to 
decrease diffusion, clean the inner surface of the tubing 
and eliminate any cross contamination. Collected 
samples are placed in standard 1.5 mL centrifuge 
tubes, covered by airtight silicon cap and stored at a 
refrigerated fraction collector. A cross-over study had 
been designed to compare the effects of manual and 
ABS methods on the pharmacokinetic parameters 
of carbamazepine (Zhu et al., 2005). They found a 
significant difference of the concentration ratio of 
carbamazepine and its metabolite from the two sampling 
techniques. The authors concluded that the physical 
stress influenced blood flow and distribution impacting 
drug absorption, distribution and metabolism, resulting 
in the differences of pharmacokinetic parameters 
obtained by the two techniques. One drawback of 
ABS is that the catheter implantation of the rats clearly 
causes an initial stress response, but the animals usually 
recover quickly and gain a cyclical diurnal rhythmicity 
18 h after surgery (Royo et al., 2004). Therefore, the 
ABS still provides a major advantage by allowing free 
movement, which can minimize the stress caused by the 
restraint or anesthesia.
Sample preparation
Sample preparation must be done before LC/MS 
analysis to improve the performance of assay. The goal 
of sample preparation is to selectively separate the 
analyte from the matrix, which diminishes interference 
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and thus increases sensitivity. Specific considerations 
include the removal of protein or non-protein material 
that may deteriorate column, the elimination of 
nonvolatile salts that suppress ionization, and the 
concentration of trace amounts of analyte (Chien et 
al., 2011; Dams et al., 2003). The common processes 
of sample preparation discussed in this section include 
protein precipitation (PPT), liquid-liquid extraction 
(LLE) and solid-phase extraction (SPE).
Protein precipitation
PPT of plasma sample by acetonitrile or methanol 
is a simple and quick method for biological sample 
preparation, because this method requires low cost and 
minimal method development procedures. Recently, 
the integration of robotic liquid handling module with 
peripheral devices realized automated PPT steps, 
such as sequential completion of the centrifugation, 
plate sealing, piercing and supernatant transferring, 
and reduced manual labor and reduced possibility of 
systematic error due to the manual volumetric transfers 
during sample preparation (Ma et al., 2008). The major 
drawback of PPT is the more severe matrix effect 
(signal suppression) when using LC- MS/MS, because 
PPT is a non-selective sample pretreatment and the 
cleanup of the bio-fluid is limited (Bonfiglio et al., 1999; 
Dams et al., 2003). 
Liquid-liquid extraction
LLE utilizes the different solubilities of a compound 
in two different immiscible solvents to separate the 
compound from biological matrix. The manipulations 
of pH value of plasma and different extraction solvents 
can greatly enhance extraction recovery and increase the 
selectivity of method. Solvent-induced phase transition 
(SIPTE) is a combinational method using PPT and 
LLE for sample preparation, and has been proposed 
for the preparation of andrographolide, a hydrophobic 
major constituent from Andrographis Herba (穿心蓮 
chuān xīn lián), in human plasma before introducing 
them to the LC/MS system (Liu et al., 2010). Briefly, 
a hydrophobic solvent like chloroform is added into 
the mixture of acetonitrile and plasma, and the upper 
chloroform layer is collected for analysis. The samples 
processed by SIPTE can be directly injected into 
the system because nonvolatile materials have been 
excluded by the chloroform, providing an alternative 
method for biological sample pretreatment.
Solid-phase extraction
SPE is often recognized as the most effective method 
for sample preparation. A SPE cartridge can be regarded 
as a miniaturized chromatographic column, where 
analyte and matrix are retained on the surfaces of the 
solid packing material and are then eluted separately by 
manipulating different “mobile phases”. The selection of 
SPE sorbents, such as normal phase, reversed phase, ion 
exchange type and mixed model, usually depends on the 
physicochemical properties of analytes (Hennion, 1999). 
The SPE method has been used to extract saponins of 
Ginseng Radix (人參 rén shēn), including ginsenoside 
Rg1, its secondary glycoside Rh1 and aglycone 
protopanaxatriol, in a pharmacokinetic study (Sun et 
al., 2005). The analytical sensitivity could be further 
improved by a 10-fold concentrating the eluate of SPE 
by sample evaporation and reconstitution. 
The issue of matrix effects in LC/MS
Interference peaks in biological samples are easily 
observed when using HPLC coupled to ultraviolet, 
fluorescence and electrochemical detectors. These 
visible interference peaks can be removed by altering 
the chromatographic conditions, sample extraction 
method or detector. With the introduction of highly 
sensitive and selective LC-MS-based bioanalytical 
methods, sample preparation can usually be simplified 
to speed up the throughput of data. However, although 
those endogenous compounds in biological matrices 
are indiscernible in the chromatogram, they may 
induce matrix effects (ME). ME can be defined as a 
phenomenon observed when the signal of an analyte 
is either suppressed or enhanced because of the co-
eluted components that come from the sample matrix 
and influence the ionization efficiency. The issue of ME 
had been noticed by the late 1990s (Matuszewski et 
al., 1998), and has now become an imperative item for 
analytical validation (Chambers et al., 2007; O'Halloran 
and Ilett, 2008; Van De Steene and Lambert, 2008). 
As described by guidelines of the U.S. Food and Drug 
Administration, ME must be investigated to ensure that 
accuracy, precision, selectivity, and robustness in the 
HPLC-MS-based procedures, so that sensitivity will not 
be compromised (FDA, 2001). 
ME are recognized to be both analyte- and matrix-
dependent,  and exogenous compounds such as 
excipients, or the vehicle used for drug administration 
and mobile phase modifiers are all possible factors that 
can lead to ME (Schuhmacher et al., 2003). Though 
the detailed mechanism of ME is not fully understood, 
it is believed that ion suppression is a result of the 

Wu et al . / Journal of Traditional and Complementary Medicine 2 (2012) 
ionization competition between analytes and co-
eluted components (Matuszewski et al., 1998, 2003; 
Taylor, 2005). One approach to the identification of 
ME is the method of post-column infusion (Bonfiglio 
et al., 1999). In brief, the analyte of interest is infused 
constantly into the ion source of a mass spectrometer 
to produce a steady signal. The blank matrix after 
sample preparation (e.g. PPT, LLE and SPE) is then 
injected into the HPLC/MS system, which helps to 
identify the region in the chromatogram suppressed or 
enhanced by the components of the matrix. However, 
this method cannot quantitatively determine the extent 
of ME. Another approach to quantitatively assess ME is 
the post-extraction fortification method (Matuszewski 
et al., 2003). In brief, two sets of the samples are 
prepared to evaluate the matrix effect and recovery in 
the quantitative bioanalytical method. Set 1 is a neat 
solution (analyte only) prepared in the mobile phase, 
and set 2 is the analyte fortified with plasma that has 
been extracted. The value of ME is expressed as the 
ratio of the response of set 2 to the response of set 1. A 
value of > 100 % indicates ionization enhancement, and 
a value of < 100 % indicates ionization suppression. The 
other recently proposed method for assessment of ME is 
to monitor phospholipids by a mass transition m/z 184 
> 184 in the case of hydrocodone and pseudoephedrine 
determinations in human plasma (Ismaiel et al., 2007). 
Post-column infusion studies have indicated that the 
ion suppression for analytes correlates with the elution 
of phospholipids, and therefore chromatographic 
conditions were optimized to resolve the peaks of 
interest from the phospholipids. The authors concluded 
that this is useful in method development and in 
routine analysis to avoid the ME (Ismaiel et al., 2007). 
Generally, four aspects can be considered to reduce 
ME. The first way is to change the methods of sample 
preparation. PPT is likely to cause more ME than is 
produced by LLE or SPE, but the latter two methods 
require more time-consuming and tedious procedures 
(Dams et al., 2003). Secondly, ME can be avoided by 
adjusting chromatographic parameters. Many papers 
have pointed out that the appropriate chromatography 
is necessary to reduce ME (Chambers et al., 2007; 
Kloepfer et al., 2005; Niessen et al., 2006), and as 
mentioned above, using columns with different retention 
mechanisms (e.g. HILIC for polar compounds) may 
be of great help. Thirdly, trying different ionization 
interfaces such as atmospheric pressure chemical 
ionization and atmospheric pressure photoionization is 
also effective. Finally, the use of a stable-isotope-labeled 
compound as the internal standard can compensate 
for ME because the ion currents of the analyte and the 
internal standard are both affected by the matrix effect 
in a similar manner (Haubl et al., 2006; Schuhmacher et 
al., 2003). 
Pharmacok ine t i c s  o f  po lypheno l i c 
components from Chinese medicinal herbs
(-)-epigallocatechin-3-gallate from green tea
Green tea is a species of Camellia sinensis , an 
evergreen shrub belonging to Theaceae family, and 
the medicinal use of green tea can be dated back to 
thousands of years ago (Liu et al., 2008). Green tea 
has been demonstrated to have various biological 
activities, such as anti-oxidation (Serafini et al., 
1996), anti-inflammation (Chan et al., 1998), cancer 
prevention (Nakachi et al., 2000) and increasing energy 
expenditure (Dulloo et al., 1999). We have developed a 
liquid chromatography with tandem mass spectrometry 
(LC-MS/MS) and applied ABS to investigate the 
pharmacokinetics of (-)-epigallocatechin-3-gallate 
(EGCG, Figure 1.), one of the major polyphenols 
contained in green tea, by a conscious and freely 
moving rat model (Lin et al., 2007). The precursor 
ion [M-H]- of EGCG (m/z  = 457) was generated by 
a negative ionization mode, and the transition of the 
precursor ion to the product ion (m/z = 169) for EGCG 
was monitored by the multiple-reaction monitoring 
(MRM) used for quantification. The internal standard 
(theophylline) was monitored using the MRM mode at 
m/z  transitions of 187 to 164. The limit of quantification 
(LOQ) of EGCG in rat plasma was 5 ng/mL, which 
was sensitive enough to determine EGCG after oral 
administration. We used a two-compartmental model to 
Figure 1. The chemical structure of (-)-epigallocatechin-3-gallate.

Wu et al . / Journal of Traditional and Complementary Medicine 2 (2012) 
Table 1. Pharmacokinetics of (-)-epigallocatechin gallate (EGCG) obtained by different sampling methods in rodents
Animal/ 
blood sampling site
Dose (mg/kg)/
Administration route Pharmacokinetic parameters Analytical method References
Sprague–Dawley rats/ 
from retro-orbital plexus
10 mg/kg, IV;
75 mg/kg, PO
PO group:
Cmax = 19.8 ± 3.5 ng/mL
Tmax = 85.5 ± 42.0 min
t1/2 = 16.8 ± 9.3 min
AUC = 17.4 ± 7.0 μg min/mL
BA = 1.6 ± 0.6 %
LC-EC,
Applied potential: -10 mV
LOQ: 6 ng/mL
(Chen et al., 1997)
Sprague–Dawley rats/
from jugular vein catheter by ABS 1 mg/kg, IV
t1/2 = 1.55 ± 0.14 min
AUC = 5147 ± 34 ng min/mL
LC-EC,
Applied potential: +600 mV 
(vs. Ag/AgCl)
LOQ: 5 ng/mL
(Long et al., 2001)
Sprague–Dawley rats/
from jugular vein catheter by ABS
10 mg/kg, IV;
100 mg/kg, PO
PO group:
Cmax = 1.52 ± 0.11 mg /mL
Tmax =  24 ± 7 min
t1/2 = 48 ± 13 min
AUC =  80 ± 16 μg min/mL
BA = 4.95 %
LC/MS,
MRM: m/z  457→169
LOQ: 5 ng/mL 
(Lin et al., 2007)
Sprague–Dawley rats/
from retro-orbital plexus 63.84 mg/kg, IV t1/2 = 68.6 min
LC-UV,
Wavelength: 280 nm,
LOD: 0.5 μg/mL
(Fu et al., 2008)
Wistar rats/
from retro-orbital plexus 101.76 mg/kg, PO
Cmax = 55.29 ± 1.70 ng/mL
Tmax = 1 h
t1/2 = 2.04 ± 0.2 h
AUC =510.16 ± 9.88 ng h/mL
TLC-UV,
LOQ: not mentioned (Kale et al., 2010)
IV, intravenous; PO, per os; Cmax, maximum drug concentration; Tmax, time to reach peak concentration; t1/2, elimination half-life; AUC, area 
under the concentration versus time curve; BA, oral bioavailability; LC-EC, liquid chromatography with electrochemical detection; LOQ, 
limit of quantification; LC/MS, liquid chromatography with mass spectrometric detection; MRM, multiple-reaction monitoring; LC-UV, liquid 
chromatography with ultraviolet detection; LOD, limit of detection; TLC-UV, thin-layer chromatography with ultraviolet detection.
describe the pharmacokinetics of EGCG in the rat blood 
after intravenous administration (10 mg/kg, iv). The 
average oral bioavailability of EGCG obtained in the 
work was 4.95%, which was higher than another study 
obtained by blood sampling from retro-orbital plexus 
(Chen et al., 1997). The pharmacokinetics of EGCG 
obtained by different sampling methods in rodents was 
summarized in Table 1. 
Curcumin from turmeric
Turmeric is a culinary spice derived from the 
root Curcuma longa , a member of the ginger family, 
Zingiberaceae. Turmeric is broadly used in south 
and southeast tropical Asia as a culinary spice and a 
remedy against skin diseases and colic inflammatory 
disorders in folk medicine (Villegas et al., 2008). 
Curcumin [1,7-bis(4-hydroxy-3-methoxyphenyl)-1, 
6-heptadiene-3, 5-dione, Figure 2.] is a natural 
polyphenolic compound derived from the rhizomes of 
turmeric, and curcumin possesses antioxidant, anti-
Figure 2. The chemical structure of curcumin.
inflammatory and potential cancer chemopreventive 
activities (Ammon and Wahl, 1991; Conney et al., 
1997; Sharma, 1976). Our previous study have 
presented a LC/MS method and an ABS system to 
investigate the pharmacokinetics of curcumin by a 
conscious and freely moving rat model (Yang et al., 
2007). The precursor ion [M-H]- of curcumin (m/z  = 
367) was generated by a negative ionization mode, 
and the transition of the precursor ion to the product 
ion (m/z  = 217) for curcumin was monitored by the 
MRM used for quantification. The internal standard 
(honokiol) was monitored using the MRM mode at m/z 
transitions of 265 to 224. The limit of detection and 
LOQ of curcumin in the rat plasma were 1 and 5 ng/ml, 
respectively. We used a non-compartmental model to 
describe the pharmacokinetics of curcumin in the rat 
blood after intravenous administration (10 mg/kg, iv). 
The average oral bioavailability of curcumin obtained in 
the work was 1 %. The pharmacokinetics of curcumin 
obtained by different sampling methods in rodents was 
summarized in Table 2. 
Acteoside from Cistanches Herba
Cistanches Herba is the dried succulent stems of the 
Cistanche plants, and has been known as a superior tonic 
used for the treatment of impotence, female infertility, 
and senile constipation (Jiang and Tu, 2009). The 
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major components of cistanche include phenylethanoid 
glycosides (PhGs),  i r idoids,  l ignans,  aldi tols , 
oligosaccharides and polysaccharides. Acteoside 
(Figure 3) is one of the PhGs found in cistanche (Jiang 
and Tu, 2009). In order to know the pharmacokinetics 
of acteoside after intravenous administration and the 
bioavailability after oral administration, we applied an 
ABS system for blood sampling from freely moving 
rats to avoid anesthesia or restraining stress (Wu et 
al., 2006). A catheter placed in the jugular vein was 
exteriorized, fixed in the dorsal neck region and 
connected to the ABS. A 150-μL blood was collected 
after acteoside administration, and the resulting plasma 
was prepared by a solid-phase extraction process. 
Acteoside concentrations were determined by a LC/MS 
based on the MRM (m/z 623 to 161). In this study, the 
ABS system eliminated the extensive animal handling 
and restraint associated with manual blood sampling. 
Actually, a rat in this system could wander in a cage 
and access food and water freely. When blood sampling 
was conducted, no interference affects their normal 
activities. This sensitive LC/MS method can achieve 
very low quantification limit (5 ng/mL) of acteoside 
in plasma, and accurate and detailed pharmacokinetic 
profile of acteoside can be acquired. The oral 
bioavailability (BA) of acteoside was 0.12 %., and the 
low BA can be assorted to its phenolic structure, which 
is susceptible to first-pass effects in the intestinal tract 
(Donovan et al., 2001; Scalbert and Williamson, 2000).
Conclusions 
This article reviews the development of blood 
sampling methods for preclinical pharmacokinetic 
investigations and critical issues for bioanalysis using 
LC/MS. ABS systems have several advantages when 
compared with the conventional manual blood sampling 
technique, such as reduced animal use and reduced 
animal stress during blood collection. LC/MS is a 
sensitive analytical tool to determine trace amount of 
analytes in plasma, which is beneficial for researchers to 
observe the detailed pharmacokinetic profiles of drugs. 
The safety of herbal products is one of the important 
issues for the modernization of traditional Chinese 
Table 2. Pharmacokinetics of curcumin obtained by different sampling methods in rodents
Animal/ blood sampling method Dose (mg/kg)/Administration route Pharmacokinetic parameters Analytical method References
Sprague–Dawley rats/ 
not mentioned 100 mg/kg, PO
Cmax = 266.7 ng/mL
Tmax = 1.62 h
t1/2  = 5.7 h
AUC = 2609.04 ng/mL h
LC /MS,
MRM: m/z  373.2→137.1
LOQ: 0.5 ng/mL
(Liu et al., 2006)
Sprague–Dawley rats/
from jugular vein catheter under 
halothane anesthesia
10 mg/kg, IV t1/2 = 0.57 ± 0.19 hAUC = 1.67 ± 0.52 mg h/mL
LC-UV,
Wavelength: 428 nm
LOQ: 20 ng/mL
(Ma et al., 2007)
Wistar rats/ 
from jugular vein under ether 
anesthesia
1 g/kg, PO
Cmax = 0.50 μg/mL
Tmax = 0.75 h
t1/2 = 1.45 h
LC-UV,
Wavelength: 425 nm,
LOD: 25 ng/mL
(Maiti et al., 2007)
Sprague–Dawley rats/
from jugular vein catheter by ABS
10 mg/kg, IV
500 mg/kg, PO
PO group:
Cmax = 0.06 ± 0.01 μg/mL
Tmax = 41.7 ± 5.4 min
t1/2 = 44.5 ± 7.5 min
BA = 1 %
LC /MS,
MRM: m/z  367→217
LOQ: 2.5 ng/mL
(Yang et al., 2007)
Wistar rats/ 
from retro-orbital plexus 1 g/kg, PO
Cmax = 258.64 ng/mL
Tmax = 1.72 h
t1/2 = 1.28 h
AUC = 2483.32 ng/mL h
Not mentioned (Gupta and Dixit, 2011)
PO, per os; Cmax, maximum drug concentration; Tmax, time to reach peak concentration; t1/2, elimination half-life; AUC, area under the concentration 
versus time curve; LC/MS, liquid chromatography with mass spectrometric detection; MRM, multiple-reaction monitoring; LOQ, limit of 
quantification; IV, intravenous; LC-UV, liquid chromatography with ultraviolet detection; LOD, limit of detection; BA, oral bioavailability.
Figure 3. The chemical structure of acteoside.
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medicine, because people have been aware of potential 
adverse drug reactions due to inappropriate use of herbs 
or herb-drug interactions. Pharmacokinetic studies 
help us to understand the absorption, distribution, 
metabolism and elimination of medicinal herbs, which 
is very useful to design the rational and optimal dose 
regimen of the herbal formula.
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